Masahiko Inamori Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

11/2011	Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer.
1/2011	Covered stent placement for duodenal obstruction in pancreatic cancer.
12/2008	Anaplastic carcinoma of the pancreas producing granulocyte-colony stimulating factor: a case report.
10/2008	Inhibition of peroxisome proliferator-activated receptor gamma activity suppresses pancreatic cancer cell motility.
1/2008	[Which is the best monitoring study (tumor marker, computed tomography or 18F-fluoro-2-deoxy-D-glucose positron emission tomography) to evaluate efficacy of chemotherapy on unresectable pancreatic cancer ?].
2/2006	[Clinical features of long time survivors with unresectable pancreatic cancer treated by gemcitabine alone].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masahiko Inamori Research Topics

Disease

15	Neoplasms (Cancer) 05/2019 - 01/2006
14	Hemorrhage 09/2019 - 01/2004
12	Non-alcoholic Fatty Liver Disease 07/2012 - 05/2007
11	Carcinogenesis 10/2012 - 10/2007
8	Fibrosis (Cirrhosis) 02/2010 - 01/2007
7	Inflammation (Inflammations) 02/2010 - 12/2002
6	Colorectal Neoplasms (Colorectal Cancer) 02/2017 - 05/2009
6	Aberrant Crypt Foci 09/2012 - 12/2008
6	Pancreatic Neoplasms (Pancreatic Cancer) 11/2011 - 02/2006
6	Insulin Resistance 07/2010 - 01/2007
5	Peptic Ulcer (Peptic Ulcers) 01/2012 - 11/2009
5	Ulcerative Colitis 04/2011 - 01/2008
4	Esophagitis 01/2017 - 05/2006
4	Body Weight (Weight, Body) 07/2014 - 07/2010
4	Esophageal and Gastric Varices (Esophageal Varices) 11/2013 - 05/2006
4	Gastroesophageal Reflux (GERD) 11/2012 - 09/2008
4	Ulcer 10/2012 - 01/2004
4	Infections 05/2011 - 03/2005
4	Diabetes Mellitus 09/2010 - 12/2007
4	Colonic Neoplasms (Colon Cancer) 07/2009 - 11/2007
3	Weight Loss (Weight Reduction) 07/2021 - 11/2010
3	Hepatocellular Carcinoma (Hepatoma) 05/2017 - 09/2008
3	Stomach Neoplasms (Stomach Cancer) 01/2013 - 09/2008
3	Liver Diseases (Liver Disease) 01/2013 - 01/2011
3	Adenoma (Adenomas) 10/2012 - 02/2011
3	Type 2 Diabetes Mellitus (MODY) 11/2011 - 01/2007
3	Alcoholic Fatty Liver 01/2011 - 10/2009
3	Polyps 07/2010 - 01/2007
3	Colitis 11/2007 - 07/2002
2	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2021 - 07/2015
2	Rupture 11/2013 - 04/2009
2	Chronic Renal Insufficiency 07/2013 - 01/2013
2	Peptic Esophagitis (Reflux Esophagitis) 11/2012 - 05/2006
2	Non-Erosive Reflux Disease 11/2012 - 11/2010
2	Hypertension (High Blood Pressure) 01/2012 - 04/2010
2	Dyspepsia (Indigestion) 01/2012 - 01/2011
2	Neoplasm Metastasis (Metastasis) 11/2011 - 10/2008
2	Adenocarcinoma 11/2011 - 01/2011
2	Wounds and Injuries (Trauma) 07/2011 - 10/2008
2	Autoimmune Pancreatitis 05/2011 - 01/2010
2	Dyslipidemias (Dyslipidemia) 01/2011 - 06/2010
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 05/2009 - 07/2007
2	Obesity 01/2009 - 01/2007
2	Carcinoma (Carcinomatosis) 12/2008 - 01/2006
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2002 - 07/2002
1	Gastrointestinal Hemorrhage (Hematochezia) 09/2019

Drug/Important Bio-Agent (IBA)

10	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2017 - 01/2009
8	Biomarkers (Surrogate Marker)IBA 10/2012 - 05/2007
7	Capsules (Microcapsules)IBA 01/2013 - 01/2007
5	Messenger RNA (mRNA)IBA 10/2009 - 05/2006
4	Pharmaceutical PreparationsIBA 06/2017 - 09/2009
4	AcidsIBA 09/2014 - 01/2004
4	Proteins (Proteins, Gene)FDA Link 10/2012 - 01/2007
4	AdiponectinIBA 01/2011 - 01/2007
3	Therapeutic UsesIBA 01/2017 - 07/2012
3	LactoferrinIBA 09/2014 - 07/2002
3	Glucose (Dextrose)FDA LinkGeneric 01/2013 - 10/2007
3	Insulin (Novolin)FDA Link 01/2013 - 10/2007
3	SteroidsIBA 01/2013 - 01/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2012 - 12/2002
3	LigandsIBA 11/2011 - 11/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2011 - 08/2009
3	LeptinIBA 02/2011 - 05/2009
3	Gemcitabine FDA Link 01/2011 - 02/2006
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2010 - 05/2006
3	PPAR gammaIBA 12/2008 - 11/2007
2	immunoglobulin BIBA 07/2021 - 07/2014
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013 - 05/2009
2	Proton Pump InhibitorsIBA 11/2012 - 11/2009
2	Sitagliptin Phosphate (Januvia)FDA Link 07/2012 - 11/2011
2	Omeprazole (Prilosec)FDA LinkGeneric 07/2011 - 07/2011
2	Transcription Factors (Transcription Factor)IBA 05/2011 - 10/2008
2	Hemoglobins (Hemoglobin)IBA 03/2011 - 12/2002
2	microsomal triglyceride transfer proteinIBA 01/2011 - 09/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2011 - 12/2002
2	Metformin (Glucophage)FDA LinkGeneric 09/2010 - 07/2010
2	CarcinogensIBA 07/2010 - 12/2008
2	AzoxymethaneIBA 07/2010 - 11/2007
2	LipidsIBA 07/2010 - 09/2009
2	Ezetimibe (Zetia)FDA Link 06/2010 - 09/2009
2	ORALIT (ORS)IBA 04/2010 - 12/2008
2	Immunoglobulin G (IgG)IBA 01/2010 - 12/2007
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2009 - 05/2006
2	Peroxisome ProliferatorsIBA 09/2009 - 06/2008
2	Tumor Biomarkers (Tumor Markers)IBA 07/2009 - 01/2008
2	Ethanol (Ethyl Alcohol)IBA 06/2009 - 12/2008
2	T 0070907IBA 12/2008 - 10/2008
2	Mesalamine (Mesalazine)FDA LinkGeneric 01/2008 - 11/2007
2	CytokinesIBA 12/2002 - 07/2002
2	Peroxidase (Myeloperoxidase)IBA 12/2002 - 07/2002

Therapy/Procedure

17	Therapeutics 01/2021 - 05/2006
7	Drug Therapy (Chemotherapy) 01/2017 - 02/2006
4	Gastrostomy 12/2014 - 01/2007
3	Palliative Care (Palliative Therapy) 05/2019 - 01/2005
2	Radiofrequency Ablation 05/2017 - 06/2009
2	Ligation 11/2011 - 05/2010
2	Chemoprevention 09/2010 - 07/2010
2	Enema (Enemas) 09/2009 - 08/2009
2	Argon Plasma Coagulation 01/2007 - 01/2007
2	Sclerotherapy 01/2007 - 05/2006